Status:

ACTIVE_NOT_RECRUITING

ADAPT for Adolescents Adolescents

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

University of Colorado, Denver

University of California, San Francisco

Conditions:

HIV/AIDS

Eligibility:

All Genders

14-24 years

Phase:

NA

Brief Summary

Adolescents and young adults (AYA) with HIV face unique challenges to engagement in care and their ability to achieve optimal health outcomes. The investigators hypothesize that developmentally-tailor...

Detailed Description

While the global response to HIV has reached close to 20 million persons with life-saving antiretroviral therapy (ART) and saved upwards of 60 million life-years, progress has been uneven and adolesce...

Eligibility Criteria

Inclusion

  • HIV-infection, on or initiating ART,
  • 14-24 years of age,
  • Living \> 6 months in Kisumu County, Kenya in previous year,
  • Capable of informed consent (\> 18 years) or with a legal caregiver available for consent (14-\<18 years),
  • Access to a cell phone,
  • Ability to read or be read short message service (SMS) messages,
  • Willingness to be contacted by clinic upon missed appointment,
  • For AYA who report phone sharing must have disclosed to the person sharing the phone.
  • Additionally, we will include AYA who are aware of their HIV status or whose caregivers agree to assisted disclosure.

Exclusion

  • AYA who participated in ADAPT-R,
  • Those planning to move out of Kisumu County, those acutely ill and requiring hospitalization,
  • Those who report sharing phones but have not disclosed to the person sharing the phone

Key Trial Info

Start Date :

April 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2025

Estimated Enrollment :

880 Patients enrolled

Trial Details

Trial ID

NCT04432571

Start Date

April 6 2021

End Date

December 31 2025

Last Update

December 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kenya Medical Research Institute

Kisumu, Kenya